We use cookies and similar technologies for analytics, to understand how the site is used. You can accept or decline non-essential cookies. See our Privacy Policy.
Based on 10 analysts
Target prices reflect the market consensus (mean/high/low), not individual research firms. 5 actions collected · 5 in the last 12 months.
| Date | Firm | Analyst | Action | Rating change | Price target | Report |
|---|---|---|---|---|---|---|
| 2026. 05. 08. | Chardan Capital | — | Maintain | Buy → Buy | — | Chardan Capital: Buy |
| 2026. 04. 11. | Chardan Capital | — | Maintain | Buy → Buy | — | Chardan Capital: Buy |
| 2026. 03. 06. | UBS | — | Maintain | Neutral → Neutral | — | UBS: Neutral |
| 2026. 03. 03. | Citizens | — | Upgrade | Market Perform → Market Outperform | — | Citizens: Market Perform → Market Outperform |
| 2026. 02. 26. | Barclays | — | Maintain | Overweight → Overweight | — | Barclays: Overweight |
Past rating changes by firm, agreement/divergence within the sector, and what target changes mean.